Extramural review of clinical response of breast cancer to cytotoxic chemotherapy
β Scribed by Mary E. Sears; Kenneth B. Olson
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 199 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We reviewed 89 patients with disseminated breast cancer who had at least one valid estrogen receptor (ER) assay and who underwent one or several trials of chemotherapy. The responses were assessed by two independent extramural reviewers. Of the 89 patients, 81 were evaluable; 28 of 36 (77.8%) ER-pos
## Abstract Despite proven benefits of neoadjuvant chemotherapy in patients with locally advanced, invasive breast cancer, no regimen is recommended as the treatment of choice. Neoadjuvant chemotherapy regimens encompass singleβagent and combination therapy and sequential treatment. For this report